Vitiligo associated with subcutaneous insulin lispro infusion in type 1 diabetes.
Burge
Mark R
MR
Carey
J David
JD
D000328:Adult; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects; D007328:Insulin / Q000009:adverse effects* / Q000031:analogs & derivatives*; D007332:Insulin Infusion Systems / Q000009:adverse effects*; D061268:Insulin Lispro; D014820:Vitiligo / Q000139:chemically induced*
D007004:Hypoglycemic Agents; D007328:Insulin; D061268:Insulin Lispro